{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:54:01Z","timestamp":1781517241172,"version":"3.54.1"},"reference-count":52,"publisher":"China Science Publishing & Media Ltd.","issue":"6","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,6,1]]},"DOI":"10.3724\/abbs.2025152","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T11:33:05Z","timestamp":1755171185000},"page":"1374-1386","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["A &amp;lt;italic&amp;gt;Mycobacterium tuberculosis&amp;lt;\/italic&amp;gt;                     multi-epitope DNA vaccine encoding adaptive immune antigens provokes IFN&amp;gamma;\/Th1                     immunity and confers potential protection"],"prefix":"10.3724","volume":"58","author":[{"given":"Jingyao","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiuan Yee","family":"Leow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoqian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"Bagcchi S","year":"2022","unstructured":"Bagcchi S. WHO\u2019s global tuberculosis report 2022. Lancet                             Microbe, 2022, 4:","journal-title":"Lancet                             Microbe"},{"key":"CITATION2","doi-asserted-by":"crossref","unstructured":"Shuqi W, Qing S, Guanglu J, Hairong H, Guirong W, Hao L. Mycobacterium                         tuberculosis persister cell formation after pyrazinamide.                                                       Zoonoses                          2024, 4: ZOONOSES-2024-0025.","DOI":"10.15212\/ZOONOSES-2024-0025"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/14787210.2023.2240022","volume":"21","author":"Mahmoud M","year":"2023","unstructured":"Mahmoud M, Tan Y. New advances in the treatments of drug-resistant tuberculosis. Expert Rev                             Anti-infective Ther, 2023, 21: 863-870.","journal-title":"Expert Rev                             Anti-infective Ther"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"103993","DOI":"10.1016\/j.ebiom.2022.103993","volume":"79","author":"Dockrell HM","year":"2022","unstructured":"Dockrell HM, McShane H. Tuberculosis vaccines in the era of Covid-19 - what is taking us                         so long?. eBioMedicine, 2022, 79:","journal-title":"eBioMedicine"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.4049\/jimmunol.2000563","volume":"205","author":"Aagaard C","year":"2020","unstructured":"Aagaard C, Knudsen NPH, Sohn I, Izzo AA, Kim H, Kristiansen EH, Lindenstr\u00f8m T. Immunization with Mycobacterium tuberculosis-specific                         antigens bypasses T cell differentiation from prior bacillus calmette-gu\u00e9rin                         vaccination and improves protection in mice. J Immunol, 2020, 205: 2146-2155.","journal-title":"J Immunol"},{"key":"CITATION6","doi-asserted-by":"crossref","unstructured":"Jie W, Jie M, Yan L. RNA-seq analysis of the BCG vaccine in a                         humanized mouse.                                                       Zoonoses                          2023, 3: ZOONOSES-2022-0035.","DOI":"10.15212\/ZOONOSES-2022-0035"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"1238586","DOI":"10.3389\/fimmu.2023.1238586","volume":"14","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Xu J, Hu Z, Fan X. Advances in protein subunit vaccines against tuberculosis. Front Immunol, 2023, 14:","journal-title":"Front Immunol"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3390\/genes13122287","volume":"13","author":"Melo ARS","year":"2022","unstructured":"Melo ARS, de Mac\u00eado LS, Inven\u00e7\u00e3o MCV, de Moura IA, da Gama MATM, de Melo CML, Silva AJD. Third-generation vaccines: features of nucleic acid vaccines and                         strategies to improve their efficiency. Genes, 2022, 13:","journal-title":"Genes"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2021.02.030","volume":"184","author":"Gebre MS","year":"2021","unstructured":"Gebre MS, Brito LA, Tostanoski LH, Edwards DK, Carfi A, Barouch DH. Novel approaches for vaccine development. Cell, 2021, 184: 1589-1603.","journal-title":"Cell"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/vaccines7020037","volume":"7","author":"Liu MA","year":"2019","unstructured":"Liu MA. A comparison of plasmid DNA and mRNA as vaccine technologies. Vaccines, 2019, 7:","journal-title":"Vaccines"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"115340","DOI":"10.1016\/j.addr.2024.115340","volume":"210","author":"Wang C","year":"2024","unstructured":"Wang C, Yuan F. A comprehensive comparison of DNA and RNA vaccines. Adv Drug                             Deliver Rev, 2024, 210:","journal-title":"Adv Drug                             Deliver Rev"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"7757","DOI":"10.1038\/s41598-022-11851-z","volume":"12","author":"Alizadeh M","year":"2022","unstructured":"Alizadeh M, Amini-Khoei H, Tahmasebian S, Ghatrehsamani M, Ghatreh Samani K, Edalatpanah Y, Rostampur S. Designing a novel multi\u2011epitope vaccine against ebola virus using                         reverse vaccinology approach. Sci Rep, 2022, 12:","journal-title":"Sci Rep"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/vaccines11071264","volume":"11","author":"Khalid K","year":"2023","unstructured":"Khalid K, Poh CL. The promising potential of reverse vaccinology-based                         next-generation vaccine development over conventional vaccines against                         antibiotic-resistant bacteria. Vaccines, 2023, 11:","journal-title":"Vaccines"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"1457327","DOI":"10.3389\/fimmu.2024.1457327","volume":"15","author":"Kazakova A","year":"2024","unstructured":"Kazakova A, Zhelnov P, Sidorov R, Rogova A, Vasileva O, Ivanov R, Reshetnikov V. DNA and RNA vaccines against tuberculosis: a scoping review of                         human and animal studies. Front Immunol, 2024, 15:","journal-title":"Front Immunol"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.vaccine.2010.10.022","volume":"29","author":"Govender L","year":"2010","unstructured":"Govender L, Abel B, Hughes EJ, Scriba TJ, Kagina BMN, de Kock M, Walzl G. Higher human CD4 T cell response to novel mycobacterium                         tuberculosis latency associated antigens Rv2660 and Rv2659 in latent                         infection compared with tuberculosis disease. Vaccine, 2010, 29: 51-57.","journal-title":"Vaccine"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"1110843","DOI":"10.3389\/fimmu.2023.1110843","volume":"14","author":"Liang Y","year":"2023","unstructured":"Liang Y, Li X, Yang Y, Xiao L, Liang Y, Mi J, Xue Y. Preventive effects of Mycobacterium tuberculosis                         DNA vaccines on the mouse model with latent tuberculosis infection. Front Immunol, 2023, 14:","journal-title":"Front Immunol"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3390\/biom13060968","volume":"13","author":"Anes E","year":"2023","unstructured":"Anes E, Pires D, Mandal M, Azevedo-Pereira JM. ESAT-6 a major virulence factor of Mycobacterium                         tuberculosis. Biomolecules, 2023, 13:","journal-title":"Biomolecules"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ijtb.2019.04.012","volume":"66","author":"Yousefi Avarvand A","year":"2019","unstructured":"Yousefi Avarvand A, Khademi F, Tafaghodi M, Ahmadipour Z, Moradi B, Meshkat Z. The roles of latency-associated antigens in tuberculosis vaccines. Ind J                             Tuberculosis, 2019, 66: 487-491.","journal-title":"Ind J                             Tuberculosis"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"1255920","DOI":"10.3389\/fimmu.2023.1255920","volume":"14","author":"Guo F","year":"2023","unstructured":"Guo F, Wei J, Song Y, Li B, Qian Z, Wang X, Wang H. Immunological effects of the PE\/PPE family proteins of Mycobacterium                         tuberculosis and related vaccines. Front Immunol, 2023, 14:","journal-title":"Front Immunol"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/cells10010161","volume":"10","author":"Kramarska E","year":"2021","unstructured":"Kramarska E, Squeglia F, De Maio F, Delogu G, Berisio R. PE_PGRS33, an important virulence factor of Mycobacterium                         tuberculosis and potential target of host humoral immune response. Cells, 2021, 10:","journal-title":"Cells"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"ftx100","DOI":"10.1093\/femspd\/ftx100","volume":"75","author":"Minerva M","year":"2017","unstructured":"Minerva M, De Maio F, Camassa S, Battah B, Ivana P, Manganelli R, Sanguinetti M. Evaluation of PE_PGRS33 as a potential surface target for humoral                         responses against Mycobacterium tuberculosis. Pathogens Dis, 2017, 75:","journal-title":"Pathogens Dis"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"108497","DOI":"10.1016\/j.exppara.2023.108497","volume":"248","author":"Ahmed S","year":"2023","unstructured":"Ahmed S, Rahman MN, Hasan M, Hasan MA, Mia MM. Immunogenic multi-epitope-based vaccine development to combat                         cyclosporiasis of immunocompromised patients applying computational biology                         method. Exp                             Parasitology, 2023, 248:","journal-title":"Exp                             Parasitology"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"25382","DOI":"10.1038\/s41598-024-74438-w","volume":"14","author":"Momajadi L","year":"2024","unstructured":"Momajadi L, Khanahmad H, Mahnam K. Designing a multi-epitope influenza vaccine: an immunoinformatics                         approach. Sci Rep, 2024, 14:","journal-title":"Sci Rep"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"1383098","DOI":"10.3389\/fimmu.2024.1383098","volume":"15","author":"Passos BBS","year":"2024","unstructured":"Passos BBS, Ara\u00fajo-Pereira M, Vinhaes CL, Amaral EP, Andrade BB. The role of ESAT-6 in tuberculosis immunopathology. Front Immunol, 2024, 15:","journal-title":"Front Immunol"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1189\/jlb.0912435","volume":"94","author":"Kim JS","year":"2013","unstructured":"Kim JS, Kim WS, Choi HG, Jang B, Lee K, Park JH, Kim HJ. Mycobacterium tuberculosis RpfB drives Th1-type                         T cell immunity via a TLR4-dependent activation of dendritic cells. J Leukoc Biol, 2013, 94: 733-749.","journal-title":"J Leukoc Biol"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"1325227","DOI":"10.3389\/fphar.2023.1325227","volume":"14","author":"Shah M","year":"2023","unstructured":"Shah M, Khan F, Ahmad I, Deng CL, Perveen A, Iqbal A, Nishan U. Computer-aided identification of Mycobacterium                         tuberculosis resuscitation-promoting factor B (RpfB) inhibitors                         from Gymnema sylvestre natural products. Front Pharmacol, 2023, 14:","journal-title":"Front Pharmacol"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/1040841X.2016.1185603","volume":"43","author":"Khan N","year":"2017","unstructured":"Khan N, Vidyarthi A, Amir M, Mushtaq K, Agrewala JN. T-cell exhaustion in tuberculosis: pitfalls and prospects. Crit Rev                             Microbiol, 2017, 43: 133-141.","journal-title":"Crit Rev                             Microbiol"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"e0011094","DOI":"10.1371\/journal.pntd.0011094","volume":"17","author":"Kiflie A","year":"2023","unstructured":"Kiflie A, Bewket G, Tajebe F, Abate E, Sch\u04e7n T, Blomgran R, Periago MV. Helminth species-specific effects on IFN-\u03b3 producing T cells                         during active and latent tuberculosis. PLoS Negl                             Trop Dis, 2023, 17:","journal-title":"PLoS Negl                             Trop Dis"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/j.drudis.2020.09.005","volume":"25","author":"Sefidi-Heris Y","year":"2020","unstructured":"Sefidi-Heris Y, Jahangiri A, Mokhtarzadeh A, Shahbazi MA, Khalili S, Baradaran B, Mosafer J. Recent progress in the design of DNA vaccines against                         tuberculosis. Drug Discov                             Today, 2020, 25: 1971-1987.","journal-title":"Drug Discov                             Today"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/vaccines1030225","volume":"1","author":"Williams J","year":"2013","unstructured":"Williams J. Vector design for improved DNA vaccine efficacy, safety and                         production. Vaccines, 2013, 1: 225-249.","journal-title":"Vaccines"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/vaccines11061090","volume":"11","author":"Khamjan NA","year":"2023","unstructured":"Khamjan NA, Lohani M, Khan MF, Khan S, Algaissi A. Immunoinformatics strategy to develop a novel universal multiple                         epitope-based COVID-19 vaccine. Vaccines, 2023, 11:","journal-title":"Vaccines"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"100026","DOI":"10.1016\/j.dcit.2024.100026","volume":"2","author":"Zhuang L","year":"2024","unstructured":"Zhuang L, Zhao Y, Yang L, Li L, Ye Z, Ali A, An Y. Harnessing bioinformatics for the development of a promising                         multi-epitope vaccine against tuberculosis: the ZL9810L vaccine. Decoding Infect                             Transmission, 2024, 2:","journal-title":"Decoding Infect                             Transmission"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1038\/s41467-020-16143-6","volume":"11","author":"Beckwith KS","year":"2020","unstructured":"Beckwith KS, Beckwith MS, Ullmann S, S\u00e6tra RS, Kim H, Marstad A, \u00c5sberg SE. Plasma membrane damage causes NLRP3 activation and pyroptosis                         during Mycobacterium tuberculosis infection. Nat Commun, 2020, 11:","journal-title":"Nat Commun"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","volume":"511","author":"Mayer-Barber KD","year":"2014","unstructured":"Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, Gonzales J, Derrick SC. Host-directed therapy of tuberculosis based on interleukin-1 and                         type I interferon crosstalk. Nature, 2014, 511: 99-103.","journal-title":"Nature"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","volume":"43","author":"Betts JC","year":"2002","unstructured":"Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium                         tuberculosis persistence by gene and protein expression profiling. Mol                             Microbiol, 2002, 43: 717-731.","journal-title":"Mol                             Microbiol"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/00365548.2014.982167","volume":"47","author":"Yihao D","year":"2015","unstructured":"Yihao D, Hongyun H, Maodan T. Latency-associated protein Rv2660c of Mycobacterium                         tuberculosis augments expression of proinflammatory cytokines in                         human macrophages by interacting with TLR2. Infect Dis, 2015, 47: 168-177.","journal-title":"Infect Dis"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/eji.200324038","volume":"33","author":"Fieschi C","year":"2003","unstructured":"Fieschi C, Casanova J. Mini-review The role of interleukin-12 in human infectious                         diseases: only a faint signature. Eur J Immunol, 2003, 33: 1461-1464.","journal-title":"Eur J Immunol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/sj.icb.7100019","volume":"85","author":"Birkness KA","year":"2007","unstructured":"Birkness KA, Guarner J, Sable SB, Tripp RA, Kellar KL, Bartlett J, Quinn FD. An in vitro model of the leukocyte interactions                         associated with granuloma formation in Mycobacterium tuberculosis                         infection. Immunol Cell Biol, 2007, 85: 160-168.","journal-title":"Immunol Cell Biol"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/art.27271","volume":"62","author":"Lin PL","year":"2010","unstructured":"Lin PL, Myers A, Smith LK, Bigbee C, Bigbee M, Fuhrman C, Grieser H. Tumor necrosis factor neutralization results in disseminated                         disease in acute and latent Mycobacterium tuberculosis                         infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheumatism, 2010, 62: 340-350.","journal-title":"Arthritis Rheumatism"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1080\/07391102.2023.2208214","volume":"42","author":"Chouhan M","year":"2024","unstructured":"Chouhan M, Tiwari PK, Moustafa M, Chaubey KK, Gupta A, Kumar R, Sahoo AK. Inhibition of Mycobacterium tuberculosis                         resuscitation-promoting factor B (RpfB) by microbially derived natural                         compounds: a computational study. J Biomol                             Structure Dyn, 2024, 42: 948-959.","journal-title":"J Biomol                             Structure Dyn"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-2334-7-146","volume":"7","author":"Biketov S","year":"2007","unstructured":"Biketov S, Potapov V, Ganina E, Downing K, Kana BD, Kaprelyants A. The role of resuscitation promoting factors in pathogenesis and                         reactivation of Mycobacterium tuberculosis during                         intra-peritoneal infection in mice. BMC Infect Dis, 2007, 7:","journal-title":"BMC Infect Dis"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/mi.2011.10","volume":"4","author":"Urdahl KB","year":"2011","unstructured":"Urdahl KB, Shafiani S, Ernst JD. Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunol, 2011, 4: 288-293.","journal-title":"Mucosal Immunol"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/376352a0","volume":"376","author":"Rickert RC","year":"1995","unstructured":"Rickert RC, Rajewsky K, Roes J. Impairment of T-cell-dependent B-cell responses and B-l cell                         development in CD19-deficient mice. Nature, 1995, 376: 352-355.","journal-title":"Nature"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijms25010010","volume":"25","author":"Tkachenko A","year":"2024","unstructured":"Tkachenko A, Kupcova K, Havranek O. B-cell receptor signaling and beyond: the role of Ig\u03b1 (CD79a)\/Ig\u03b2                         (CD79b) in normal and malignant B cells. Int J Mol Sci, 2024, 25:","journal-title":"Int J Mol Sci"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","volume":"23","author":"Greenwald RJ","year":"2005","unstructured":"Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu                             Rev Immunol, 2005, 23: 515-548.","journal-title":"Annu                             Rev Immunol"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3389\/fimmu.2019.01068","volume":"10","author":"Ivetic A","year":"2019","unstructured":"Ivetic A, Hoskins Green HL, Hart SJ. L-selectin: a major regulator of leukocyte adhesion, migration                         and signaling. Front Immunol, 2019, 10:","journal-title":"Front Immunol"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","volume":"7","author":"Crocker PR","year":"2007","unstructured":"Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol, 2007, 7: 255-266.","journal-title":"Nat Rev Immunol"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0960-9822(06)00057-1","volume":"7","author":"Nitschke L","year":"1997","unstructured":"Nitschke L, Carsetti R, Ocker B, K\u00f6hler G, Lamers MC. CD22 is a negative regulator of B-cell receptor signalling. Curr Biol, 1997, 7: 133-143.","journal-title":"Curr Biol"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"e007515","DOI":"10.1136\/jitc-2023-007515","volume":"11","author":"Chu F","year":"2023","unstructured":"Chu F, Cao J, Liu J, Yang H, Davis TJ, Kuang S, Cheng X. Chimeric antigen receptor T cells to target CD79b in B-cell                         lymphomas. J Immunother                             Cancer, 2023, 11:","journal-title":"J Immunother                             Cancer"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1182\/bloodadvances.2017015172","volume":"2","author":"Groves CJ","year":"2018","unstructured":"Groves CJ, Carrell J, Grady R, Rajan B, Morehouse CA, Halpin R, Wang J. CD19-positive antibody-secreting cells provide immune memory. Blood Adv, 2018, 2: 3163-3176.","journal-title":"Blood Adv"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"e2403438","DOI":"10.1002\/advs.202403438","volume":"11","author":"Yin S","year":"2024","unstructured":"Yin S, Li C, Shen X, Yu G, Cui L, Wu Y, He Y. Siglec-G suppresses CD8+ T cells responses through                         metabolic rewiring and can be targeted to enhance tumor immunotherapy. Adv Sci, 2024, 11:","journal-title":"Adv Sci"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"e64572","DOI":"10.1371\/journal.pone.0064572","volume":"8","author":"Yuan J","year":"2013","unstructured":"Yuan J, Yu M, Cao AL, Chen X, Zhang LH, Song Y, Cheng X. A novel epitope from CD22 regulates Th1 and Th17 cell function in                         systemic lupus erythematosus. PLoS One, 2013, 8:","journal-title":"PLoS One"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/13F8ED78B8A448A4BA265A15F03AC519","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025152","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/13F8ED78B8A448A4BA265A15F03AC519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:10:46Z","timestamp":1781514646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11,25]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2025152","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}